The resignation has sparked a review of the hospital operator’s digital and technology division. Plus, more from biotechs and pharma.
The resignation has sparked a review of the hospital operator’s digital and technology division. Plus, more from biotechs and pharma.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.